Navigation Links
Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors
Date:1/30/2008

st cancer.

About Tigris Pharmaceuticals, Inc.

Tigris Pharmaceuticals, Inc. is a privately held biopharmaceutical company that develops therapeutic technologies to treat oncology, infectious diseases and other areas of unmet medical need. Tigris is currently conducting a Phase II clinical study for A-007, its topical treatment for pre-cancerous and cancerous anogenital lesions associated with HPV. Tigris is also developing three novel, targeted small molecule oncology compounds. Tigris' mission is to efficiently move its existing and future technologies through the various stages of clinical development in order to meet patients' needs for safe and effective treatments of human illnesses.

Contact:

Anne White

Chief Operating Officer

Tigris Pharmaceuticals, Inc.

(239) 444-5400

info@tigrispharma.com

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are valid only as of today, and we disclaim any obligation to update this information. These statements are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. These statements are based on our current beliefs and expectations as to such future outcomes. Drug discovery and development involve a high degree of risk. Factors that might cause such a material difference include, among others, uncertainties related to the ability to attract and retain partners for our technologies, the identification of lead compounds, the successful preclinical development thereof, the completion of clinical trials, the FDA review process and other governmental regulation, our pharmaceutical collaborator's ability to successfully develop and commercialize drug candidates, competition from other pharmaceutical companies, product pricing and third par
'/>"/>

SOURCE Tigris Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
2. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
3. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
4. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
5. Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168
6. Cerimon Pharmaceuticals Initiates Phase II/III Clinical Studies to Evaluate its Diclofenac Patch for Mild to Moderate Pain
7. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
8. First Patient Enrolled in Cogentus Pharmaceuticals Pivotal Phase 3 Trial of Novel Combination Medicine
9. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
10. Vion Pharmaceuticals Announces FDA Lift of Clinical Hold on Phase III Study of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed AML
11. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014 According to ... (Cryotherapy, Heat, therapy, Hydrotherapy), Accessories (Posture Mirror, Exercise Ball), ... technologies - Global Forecast to 2019" published by ... reach $19,786.3 Million by 2019 from $14,240.0 Million ... 2014 to 2019. Browse 74 market ...
(Date:9/19/2014)... N.J. , Sept. 19, 2014 Merck (NYSE: ... States and Canada , is teaming ... Desafiando La Diabetes: Logra Tus Metas , an educational program encouraging ... blood sugar -- a key treatment goal to help reduce the ... States are at a higher risk for developing type ...
(Date:9/19/2014)... Five MinuteClinic walk-in medical clinics are opening inside select ... Three clinics opened in Memphis and ... be added in Springfield on September 24 ... expected to open October 22.  MinuteClinic is the largest and fastest ... States . The Memphis -area ...
Breaking Medicine Technology:Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 3Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 5MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3
... 8, 2012 Synteract, Inc ., a full-service ... and have two senior level directors from its Research ... in Clinical Trials Southeast conference to be held ... Barbara Conley, associate director of clinical operations, and Matt ...
... May 8, 2012   iBio, Inc. (NYSE AMEX: ... of a US patent covering compositions of matter ... polypeptides comprising the Company,s iBioModulator™ platform. The new ... is US Patent 8,173,408, entitled "Recombinant Carrier Molecule ...
Cached Medicine Technology:Synteract Sponsoring and Presenting at Outsourcing in Clinical Trials Southeast Conference 2Synteract Sponsoring and Presenting at Outsourcing in Clinical Trials Southeast Conference 3Broad Patent Protection Granted for iBio Immunomodulator 2Broad Patent Protection Granted for iBio Immunomodulator 3Broad Patent Protection Granted for iBio Immunomodulator 4
(Date:9/20/2014)... York, NY (PRWEB) September 20, 2014 ... Ariana Grande concert tickets . This popular ticket exchange ... savings. , The 2015 schedule of tours is ... music have already announced their plans to hit the road, ... Boca Raton, Fla., announced the “Honeymoon Tour,” which will take ...
(Date:9/20/2014)... Lifeinsurancequoteterm.net has released a new blog post explaining ... plan provides for vulnerable family members. , Providing ... top priority for every provider. It is now possible ... and visiting a doctor. , Life insurance plans ... up to $300,000, but only to healthy applicants. Clients ...
(Date:9/20/2014)... New PharmaPoint Drug Evaluation report, “Symbicort ... The asthma market saw very slow growth over ... with relatively efficacious standard therapies, such as short-acting ... long-acting beta-agonists (ICS/LABAs), and leukotriene modifiers, and has ... launch of seven novel targeted biologic agents and ...
(Date:9/20/2014)... 20, 2014 Traditionally dentists have advised their ... South Charlotte Dentistry is re-visiting that advice and changing ... that coffee and wine have on oral health. “There’s good ... that coffee may be beneficial in protecting against gum disease, ... The study on coffee was from the September 2014 ...
(Date:9/20/2014)... 2014 QueenBeeTickets.com is ready to offer ... performances. She will visit many cities in North America ... 16th of April. , Click Here to ... at QueenBeeTickets.com. , The star’s fans are not going ... favorite young singer in a live performance. Ariana Grande ...
Breaking Medicine News(10 mins):Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 2Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 3Health News:No Medical Exam Life Insurance Provides Financial Protection for Families 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 3Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 4Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 3Health News:Discount Ariana Grande Tickets: QueenBeeTickets.com Delights Fans with Discount Concert Tickets for Ariana Grande’s 2015 Honeymoon Tour 2
... , , , ... Dr. Raymond Boyle, Ph.D., M.P.H., will be the new Director of ... and Epidemiology from the University of Oregon and the University of ... this new addition to ClearWay Minnesota and our research department," said ...
... explain why some function fine on six hours a night , ... by just fine on six hours of sleep, and a new ... finding doesn,t appear likely to help people with insomnia. Still, it ... long as they do, said study co-author Ying-Hui Fu, a professor ...
... Aug. 13 The following statement was released today by United ... comprehensive health care has been a high priority for the disability ... Act (H.R. 3200) will make significant strides toward meeting that goal. ... , Major insurance market reforms such as ...
... , BASKING RIDGE, N.J., Aug. 13 ... record-keeping, protecting confidential patient information becomes vastly more complex. ... designed to help safeguard the growing exchange of electronic patient ... , The first offering, Verizon Security Management ...
... , , , , ... busy preparing their children for departure for school, it is just ... from bringing bed bugs home from college and their travels. ... in the New York Metropolitan area, has seen a significant increase ...
... , MIAMI BEACH, Fla., Aug. 13 Centers ... facilities in Florida at the Florida Health Care Conference in Hollywood, ... for pressure ulcer management from the Florida Agency for Health Care ... Weaver, Chief of Field Operations, Division of Managed Care and Health ...
Cached Medicine News:Health News:They Snooze Less, But They Don't Lose 2Health News:Verizon Introduces New IT Security Capabilities for Health Care Industry 2Health News:Verizon Introduces New IT Security Capabilities for Health Care Industry 3Health News:Verizon Introduces New IT Security Capabilities for Health Care Industry 4Health News:Bed Bug Epidemic and Upcoming School Breaks Could Wreak Havoc on Homeowners 2Health News:Bed Bug Epidemic and Upcoming School Breaks Could Wreak Havoc on Homeowners 3Health News:Centers of Excellence Awards Presented to Over 100 Nursing Facilities as Nursing Facilities Reach the 'Tipping Point' in Treating Pressure Ulcers 2
... Semi-Automatic Tissue Sectioning System has maintained the ... system. Researchers from around the globe have ... their fresh and fresh fixed tissue sectioning ... With the Vibratome Automatic Tissue Sectioning Systems, ...
... System provides a versatile means of sectioning ... The 1500 employs a vibrating blade ... embedding. The creation of artifacts, the ... activities, and other deleterious effect inherent in ...
The V-Block adapter is designed to allow round posts to be placed in the Vibratome vice....
... Developed specifically for the Vibratome, this ... the first time to cut thin Vibratome ... obtained with thick (1 micron) plastic sections. ... with a Vibratome 1000 of a thickness ...
Medicine Products: